Pivotal phase III trial of orally administered lefamulin in the treatment of acute bacterial skin and skin structure infections

Trial Profile

Pivotal phase III trial of orally administered lefamulin in the treatment of acute bacterial skin and skin structure infections

Planning
Phase of Trial: Phase III

Latest Information Update: 07 Jun 2012

At a glance

  • Drugs Lefamulin (Primary)
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top